Genscript Biotech Corporation (1548.HK) HKSE
Currency In HKD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.46B |
| Enterprise Value | 3.54B |
| P/E Ratio | -14.05 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 11.18 |
| Price/Book Ratio | 2.36 |
| Enterprise/Revenue | 11.22 |
| Enterprise/EBITDA | 46.15 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.75 |
| Operating Margin | 0.15 |
AD
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.16 |
Income Statement
| Revenue | 959.53M |
| Revenue/Share | 0.39 |
| Gross Profit | 553.2M |
| EBITDA | 329.29M |
| Net Income | -532.83M |
| Diluted EPS | -0.25 |
Balance Sheet
| Total Cash | 831.18M |
| Total Cash/Share | 0.38 |
| Total Debt | 254.68M |
| Total Debt/Equity | 0.07 |
| Current Ratio | 1.48 |
| Book Value Per Share | 1.79 |
Price History
| 52-Week Change | 104.6 |
| 52-Week High | 49.46 |
| 52-Week Low | 10.36 |
| Moving Average 50 Days | 35.65 |
| Moving Average 200 Days | 18.89 |
Statistics
| Average Volume | 42.35M |
| Shares Outstanding | 2.25B |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
